Alyssa Verano

This inventor holds 6 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alyssa Verano. Retrieved from https://idiyas.com/inventor/alyssa-verano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Boston, MA (US) (2021 - 2024)
Allston, MA (US) (2024)

Company Filing History:

6 out of 1,266

Dana-Farber-Cancer Institute Inc.

patents

Years Active: 2021-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12234220 - Immunomodulatory compounds (2025-02-25),

2. 12227488 - Small molecule degraders of Helios and methods of use (2025-02-18),

3. 12060366 - Bispecific degraders (2024-08-13),

4. 12030892 - CRBN modulators (2024-07-09),

5. 11945816 - Inhibitors of EGFR and/or HER2 and methods of use (2024-04-02),

6. 11186574 - Inhibitors of EGFR and/or HER2 and methods of use (2021-11-30),

Title: Top Inventor in Boston, MA

Introduction: David A. Bulpett is a prominent inventor based in Boston, Massachusetts. Notably, she is a woman who has made significant contributions to her field.

Latest Patents: David A. Bulpett holds several recent patents that showcase her innovative work and dedication to advancing technology.

Career Highlights: Throughout her career, Bulpett has achieved numerous milestones, establishing herself as a leader in her industry.

Collaborations: She has collaborated with various organizations and individuals, further enhancing her impact on the field of invention.

Conclusion: David A. Bulpett continues to inspire others with her groundbreaking work and commitment to innovation.

Profile summary based on public USPTO records.